SE8601624D0 - New pharmaceutical preparations - Google Patents

New pharmaceutical preparations

Info

Publication number
SE8601624D0
SE8601624D0 SE8601624A SE8601624A SE8601624D0 SE 8601624 D0 SE8601624 D0 SE 8601624D0 SE 8601624 A SE8601624 A SE 8601624A SE 8601624 A SE8601624 A SE 8601624A SE 8601624 D0 SE8601624 D0 SE 8601624D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical preparations
active compound
new pharmaceutical
weight
amount
Prior art date
Application number
SE8601624A
Other languages
English (en)
Swedish (sv)
Inventor
K-E L Falk
S M Hugosson
A Rosinski
J A Sjogren
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20364135&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8601624(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to SE8601624A priority Critical patent/SE8601624D0/xx
Publication of SE8601624D0 publication Critical patent/SE8601624D0/xx
Application filed by Haessle Ab filed Critical Haessle Ab
Priority to PH35003A priority patent/PH22494A/en
Priority to YU40787A priority patent/YU47258B/sh
Priority to SI8710407A priority patent/SI8710407B/sl
Priority to ZA871911A priority patent/ZA871911B/xx
Priority to NZ219633A priority patent/NZ219633A/xx
Priority to AU70043/87A priority patent/AU602677B2/en
Priority to EG171/87A priority patent/EG18265A/xx
Priority to NO871199A priority patent/NO174795B/no
Priority to ES198787850098T priority patent/ES2031929T3/es
Priority to EP87850098A priority patent/EP0249587B1/fr
Priority to AT87850098T priority patent/ATE76288T1/de
Priority to DE8787850098T priority patent/DE3779183D1/de
Priority to DK198701549A priority patent/DK173033B1/da
Priority to US07/034,500 priority patent/US4803081A/en
Priority to CA000533985A priority patent/CA1304294C/fr
Priority to MYPI87000450A priority patent/MY101553A/en
Priority to DZ870056A priority patent/DZ1067A1/fr
Priority to DD87301670A priority patent/DD263231A5/de
Priority to IE92587A priority patent/IE59419B1/en
Priority to PL1987265078A priority patent/PL265078A1/xx
Priority to UA4202349A priority patent/UA12336A/uk
Priority to JP62087250A priority patent/JPH0778016B2/ja
Priority to CN87102758A priority patent/CN1025150C/zh
Priority to KR870003416A priority patent/KR870009720A/ko
Priority to CS872587A priority patent/CS270560B2/cs
Priority to HU871622A priority patent/HU204699B/hu
Priority to PT84663A priority patent/PT84663B/pt
Priority to IS3214A priority patent/IS1553B/is
Priority to FI871585A priority patent/FI91826C/fi
Priority to SU874202349A priority patent/SU1743332A3/ru
Priority to KR1019870007169A priority patent/KR950002147B1/ko
Priority to GR920401616T priority patent/GR3005286T3/el
Priority to HRP-407/87A priority patent/HRP920630B1/xx
Priority to LV930854A priority patent/LV5395A3/xx
Priority to LTRP950A priority patent/LT2256B/xx
Priority to SG4295A priority patent/SG4295G/en
Priority to HK26795A priority patent/HK26795A/xx
Priority to CY182695A priority patent/CY1826A/xx
Priority to LV960255A priority patent/LV5757B4/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
SE8601624A 1986-04-11 1986-04-11 New pharmaceutical preparations SE8601624D0 (sv)

Priority Applications (40)

Application Number Priority Date Filing Date Title
SE8601624A SE8601624D0 (sv) 1986-04-11 1986-04-11 New pharmaceutical preparations
PH35003A PH22494A (en) 1986-04-11 1987-03-10 New pharmaceutical preparations with extended release
YU40787A YU47258B (sh) 1986-04-11 1987-03-12 Postupak za dobijanje čvrstog preparata sa produženim oslobadjanjem aktivnog jedinjenja
SI8710407A SI8710407B (sl) 1986-04-11 1987-03-12 Postopek za pridobivanje trdnega pripravka s podaljšanim sproščanjem aktivne spojine
ZA871911A ZA871911B (en) 1986-04-11 1987-03-16 New pharmaceutical preparations with extended release
NZ219633A NZ219633A (en) 1986-04-11 1987-03-16 Extended release solid preparation
AU70043/87A AU602677B2 (en) 1986-04-11 1987-03-16 New pharmaceutical preparations with extended release
EG171/87A EG18265A (en) 1986-04-11 1987-03-22 New pharmaceutical preparation with extended release
NO871199A NO174795B (no) 1986-04-11 1987-03-23 Fremgangsmåte for fremstilling av faste farmasöytiske preparater som inneholder estere og/eller etere av polyetylenglykoler som opplöseliggjörende middel
ES198787850098T ES2031929T3 (es) 1986-04-11 1987-03-25 Procedimiento para la obtencion de un preparado solido con liberacion prolongada.
DE8787850098T DE3779183D1 (de) 1986-04-11 1987-03-25 Feste pharmaceutische zubereitung mit verlaengerter wirkstofffreigabe und verfahren zur herstellung.
AT87850098T ATE76288T1 (de) 1986-04-11 1987-03-25 Feste pharmaceutische zubereitung mit verlaengerter wirkstofffreigabe und verfahren zur herstellung.
EP87850098A EP0249587B1 (fr) 1986-04-11 1987-03-25 Composition pharmaceutique solide à libération prolongée et procédé de préparation
DK198701549A DK173033B1 (da) 1986-04-11 1987-03-26 Farmaceutisk præparat med forlænget frigørelse og fremstilling deraf
US07/034,500 US4803081A (en) 1986-04-11 1987-04-03 New pharmaceutical preparations with extended release
CA000533985A CA1304294C (fr) 1986-04-11 1987-04-07 Preparations pharmaceutiques a liberation prolongee
MYPI87000450A MY101553A (en) 1986-04-11 1987-04-07 New pharmaceutical preparations with extended release.
DZ870056A DZ1067A1 (fr) 1986-04-11 1987-04-07 Nouvelles préparations pharmaceutiques à emission prolongée.
PL1987265078A PL265078A1 (en) 1986-04-11 1987-04-09 A method of new pharmaceutical agents production with a prolonged time of active matter release
DD87301670A DD263231A5 (de) 1986-04-11 1987-04-09 Verfahren zur herstellung eines festen praeparates mit verzoegerter abgabe eines wirkstoffes
IE92587A IE59419B1 (en) 1986-04-11 1987-04-09 New pharmaceutical preparations with extended release
SU874202349A SU1743332A3 (ru) 1986-04-11 1987-04-10 Способ получени таблеток
UA4202349A UA12336A (uk) 1986-04-11 1987-04-10 Спосіб отримання таблеток
JP62087250A JPH0778016B2 (ja) 1986-04-11 1987-04-10 徐放性を有する新規医薬製剤
CN87102758A CN1025150C (zh) 1986-04-11 1987-04-10 能延续释放的新药物制剂的制备方法
KR870003416A KR870009720A (ko) 1986-04-11 1987-04-10 서방형 신규 제약 제제물
CS872587A CS270560B2 (en) 1986-04-11 1987-04-10 Method of biologically active compounds solubilization
HU871622A HU204699B (en) 1986-04-11 1987-04-10 Process for prouducing pharmaceutical composition with elongated release of active ingredient and comprising an active ingredient hardly soluble in water
PT84663A PT84663B (pt) 1986-04-11 1987-04-10 Processo para a preparacao de novas composicoes farmaceuticas de accao prolongada contendo compostos activos praticamente insoluveis, especialmente dihidropiridinas substituidas
IS3214A IS1553B (is) 1986-04-11 1987-04-10 Lyfjaform með langvarandi verkun
FI871585A FI91826C (fi) 1986-04-11 1987-04-10 Menetelmä kiinteän valmisteen valmistamiseksi, josta aktiivista yhdistettä vapautuu pidennetyn ajanjakson ajan
KR1019870007169A KR950002147B1 (ko) 1986-04-11 1987-07-06 서방형 신규 제약 제제
GR920401616T GR3005286T3 (fr) 1986-04-11 1992-07-29
HRP-407/87A HRP920630B1 (en) 1986-04-11 1992-09-30 New pharmaceutical preparations having extended delivery
LV930854A LV5395A3 (lv) 1986-04-11 1993-06-30 Panemiens tablesu iegusanai
LTRP950A LT2256B (lt) 1986-04-11 1993-09-06 Tableciu gavimo budas
SG4295A SG4295G (en) 1986-04-11 1995-01-11 Solid pharmaceutical preparation with extended release and process for its preparation
HK26795A HK26795A (en) 1986-04-11 1995-03-02 Solid pharmaceutical preparation with extended release and process for its preparation
CY182695A CY1826A (en) 1986-04-11 1995-12-01 Solid pharmaceutical preparation with extended release and process for its preparation
LV960255A LV5757B4 (lv) 1986-04-11 1996-07-17 Jauni ilgstosas izdalisanas farmaceitski preparati

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8601624A SE8601624D0 (sv) 1986-04-11 1986-04-11 New pharmaceutical preparations

Publications (1)

Publication Number Publication Date
SE8601624D0 true SE8601624D0 (sv) 1986-04-11

Family

ID=20364135

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8601624A SE8601624D0 (sv) 1986-04-11 1986-04-11 New pharmaceutical preparations

Country Status (34)

Country Link
US (1) US4803081A (fr)
EP (1) EP0249587B1 (fr)
JP (1) JPH0778016B2 (fr)
KR (2) KR870009720A (fr)
CN (1) CN1025150C (fr)
AT (1) ATE76288T1 (fr)
AU (1) AU602677B2 (fr)
CA (1) CA1304294C (fr)
CS (1) CS270560B2 (fr)
CY (1) CY1826A (fr)
DD (1) DD263231A5 (fr)
DE (1) DE3779183D1 (fr)
DK (1) DK173033B1 (fr)
DZ (1) DZ1067A1 (fr)
EG (1) EG18265A (fr)
ES (1) ES2031929T3 (fr)
FI (1) FI91826C (fr)
GR (1) GR3005286T3 (fr)
HK (1) HK26795A (fr)
HU (1) HU204699B (fr)
IE (1) IE59419B1 (fr)
IS (1) IS1553B (fr)
MY (1) MY101553A (fr)
NO (1) NO174795B (fr)
NZ (1) NZ219633A (fr)
PH (1) PH22494A (fr)
PL (1) PL265078A1 (fr)
PT (1) PT84663B (fr)
SE (1) SE8601624D0 (fr)
SG (1) SG4295G (fr)
SU (1) SU1743332A3 (fr)
UA (1) UA12336A (fr)
YU (1) YU47258B (fr)
ZA (1) ZA871911B (fr)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
NO883326L (no) * 1987-08-11 1989-02-13 Bayer Ag Dhp-retard-tilberedning.
DE3738236A1 (de) * 1987-11-11 1989-05-24 Euro Celtique Sa Beisskapsel
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US4946684A (en) * 1989-06-20 1990-08-07 American Home Products Corporation Fast dissolving dosage forms
US5006344A (en) * 1989-07-10 1991-04-09 E. R. Squibb & Sons, Inc. Fosinopril tablet formulations
HU208491B (en) * 1990-11-27 1993-11-29 Gyogyszerkutato Intezet Process for producing oral pharmaceutical composition containing cyclosporin
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
US5834496A (en) * 1991-12-02 1998-11-10 Sepracor, Inc. Methods for treating hypertension using optically pure S(-) felodipine
CA2125279A1 (fr) * 1991-12-10 1993-06-24 John Sayler Coon Methodes et compositions pour reduire la resistance polymedicamenteuse
US5681812A (en) * 1991-12-10 1997-10-28 Rush Presbyterian-St. Luke's Medical Center Methods and compositions for reducing multidrug resistance
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
ES2098739T3 (es) 1992-05-13 1997-05-01 Sandoz Ltd Composiciones oftalmicas conteniendo una cyclosporin.
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
PL175026B1 (pl) 1992-09-18 1998-10-30 Yamanouchi Pharma Co Ltd Preparat typu hydrożelu o przedłużonym działaniu
JP3598049B2 (ja) * 1992-09-18 2004-12-08 山之内製薬株式会社 ハイドロゲル徐放性製剤
EP0589843B1 (fr) 1992-09-25 2001-11-28 Novartis AG Compositions pharmaceutiques comprenant de la cyclosporine
BE1006990A5 (nl) * 1993-04-22 1995-02-07 Univ Gent Werkwijze en samenstelling om een aktief bestanddeel in een vaste toedieningsvorm te brengen.
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US6726930B1 (en) * 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6676967B1 (en) * 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
US5945125A (en) * 1995-02-28 1999-08-31 Temple University Controlled release tablet
US5783212A (en) * 1996-02-02 1998-07-21 Temple University--of the Commonwealth System of Higher Education Controlled release drug delivery system
KR100321489B1 (ko) 1996-07-08 2002-10-09 에드워드 멘델 컴파니 인코포레이티드 고용량의불용성약물용서방성매트릭스
NZ336900A (en) * 1997-01-30 2001-06-29 Novartis Ag Hard gelatine capsules containing pharmaceutical compositions comprising cyclosporin A and being substantially free of any oil
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
AR017512A1 (es) 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
AR016827A1 (es) 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
US6056977A (en) * 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
SE9902742D0 (sv) * 1999-07-20 1999-07-20 Astra Ab New pharmaceutical formultion
IL143375A0 (en) * 1999-09-30 2002-04-21 Penwest Pharmaceuticals Co Sustained release matrix systems for highly soluble drugs
FR2802424B1 (fr) * 1999-12-17 2002-02-15 Adir Comprime matriciel permettant la liberation prolongee de trimetazidine apres administration par voie orale
GB0001449D0 (en) * 2000-01-21 2000-03-08 Cortendo Ab Compositions
ES2287110T3 (es) * 2000-04-11 2007-12-16 Sankyo Company, Limited Composicion farmaceutica estabilizada que contiene un bloqueador de calcio consistente en azelnidipina.
CA2311734C (fr) 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Forme pharmaceutique orale a dissolution ultra-rapide
SE0004671D0 (sv) * 2000-12-15 2000-12-15 Amarin Dev Ab Pharmaceutical formulation
WO2002056883A1 (fr) * 2001-01-18 2002-07-25 Wockhardt Limited Preparation de particules de felodipine microscopiques par microfluidisation
BR0205721A (pt) * 2001-07-06 2003-09-30 Endo Pharmaceuticals Inc Formulações de oximorfona de liberação controlada
CN100408029C (zh) * 2001-09-28 2008-08-06 麦克内尔-Ppc股份有限公司 有镶嵌部分的组合剂型
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
TWI324074B (en) * 2001-10-09 2010-05-01 Bristol Myers Squibb Co Flashmelt oral dosage formulation
EP2266590A3 (fr) 2002-02-22 2011-04-20 Shire LLC Système d'administration de substances actives et méthodes de protection et d'administration de substances actives
US6726931B2 (en) * 2002-04-08 2004-04-27 Standard Chem. & Pharm. Co., Ltd. Process for preparing oral sustained-release formulation of felodipine
ES2314227T7 (es) 2002-04-09 2012-11-19 Flamel Technologies Formulacion farmaceutica oral en forma de suspension acuosa de microcapsulas que permiten la liberacion modificada de amoxilicina.
ATE419840T1 (de) 2002-04-09 2009-01-15 Flamel Tech Sa Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen
US20030211149A1 (en) * 2002-05-07 2003-11-13 Sherman Bernard Charles Extended release tablets comprising felodipine
JP4563642B2 (ja) * 2002-05-31 2010-10-13 ワトソン ラボラトリーズ、インコーポレイテッド 医薬製剤
FR2842735B1 (fr) 2002-07-26 2006-01-06 Flamel Tech Sa Microcapsules a liberation modifiee de principes actifs peu solubles pour l'administration per os
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
US20080051411A1 (en) * 2002-12-17 2008-02-28 Cink Russell D Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
US7259186B2 (en) * 2002-12-17 2007-08-21 Abbott Laboratories Salts of fenofibric acid and pharmaceutical formulations thereof
RU2356549C2 (ru) * 2002-12-17 2009-05-27 Эббетт ГмбХ унд Ко.КГ Композиция, включающая фенофибриновую кислоту, ее физиологически приемлемую соль или производное
US20050032879A1 (en) * 2003-08-07 2005-02-10 Temple Okarter Formulations and use of a beta-blocker and an ACE-inhibitor for the treatment of cardiovascular diseases
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US8987322B2 (en) * 2003-11-04 2015-03-24 Circ Pharma Research And Development Limited Pharmaceutical formulations for carrier-mediated transport statins and uses thereof
US20070196396A1 (en) * 2004-02-11 2007-08-23 Rubicon Research Private Limited Controlled release pharmaceutical compositions with improved bioavailability
KR100598326B1 (ko) * 2004-04-10 2006-07-10 한미약품 주식회사 ＨＭＧ-ＣｏＡ 환원효소 억제제의 경구투여용 서방형 제제및 이의 제조방법
US20080152714A1 (en) * 2005-04-08 2008-06-26 Yi Gao Pharmaceutical Formulations
ES2434416T3 (es) * 2005-08-10 2013-12-16 Add Advanced Drug Delivery Technologies, Ltd. Preparación oral con liberación controlada
TW200736245A (en) * 2005-11-29 2007-10-01 Sankyo Co Acid addition salts of optically active dihydropyridine derivatives
TW200806648A (en) * 2005-11-29 2008-02-01 Sankyo Co Acid addition salts of dihydropyridine derivatives
CN101103964B (zh) * 2006-07-14 2010-09-29 海南盛科生命科学研究院 一种含有非洛地平的缓释制剂及其制备方法
US20080081067A1 (en) * 2006-10-03 2008-04-03 Gupta Manishkumar Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
JP6025820B2 (ja) 2011-04-20 2016-11-16 フリースケール セミコンダクター インコーポレイテッド 増幅器及び関連する集積回路
CN104997750B (zh) * 2015-07-30 2018-03-20 杭州康恩贝制药有限公司 一种非洛地平缓释片及其制备方法
US9687475B1 (en) 2016-03-24 2017-06-27 Ezra Pharma Llc Extended release pharmaceutical formulations with controlled impurity levels
US9675585B1 (en) 2016-03-24 2017-06-13 Ezra Pharma Extended release pharmaceutical formulations
CN109200026B (zh) * 2017-07-03 2021-01-05 北京四环科宝制药有限公司 一种非洛地平缓释片及其制备方法
CN112955965B (zh) 2018-06-14 2024-04-09 阿斯利康(英国)有限公司 使用二氢吡啶类钙通道阻断剂医药组合物降低血压的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714065A1 (de) * 1977-03-30 1978-10-12 Boehringer Mannheim Gmbh Instillationszubereitung
JPS5495721A (en) * 1978-01-11 1979-07-28 Nippon Kayaku Co Ltd Nifedipine preparation
CA1146866A (fr) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Procede de production d'un compose pharmaceutique a liberation continue sous forme solide
JPS58109412A (ja) * 1981-12-23 1983-06-29 Toa Eiyou Kagaku Kogyo Kk ニフエジピン固形製剤
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung
DE3400106A1 (de) * 1984-01-04 1985-07-11 Klaus-Dieter Dr. 3550 Marburg Bremecker Pharmazeutische zubereitungen mit gesteuerter arzneistoff-freisetzung
JPS61501511A (ja) * 1984-03-21 1986-07-24 アメリカン・ホ−ム・プロダクツ・コ−ポレイション 徐放性医薬カプセル
JPS618A (ja) * 1984-06-09 1986-01-06 Sawai Seiyaku Kk ニフエジピン含有製剤
IT1178511B (it) * 1984-09-14 1987-09-09 Pharmatec Spa Procedimento per la preparazione di una forma solida per uso orale a base di nifedipina con rilascio
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute

Also Published As

Publication number Publication date
DZ1067A1 (fr) 2004-09-13
FI91826B (fi) 1994-05-13
DK154987A (da) 1987-10-12
EP0249587B1 (fr) 1992-05-20
KR890001521A (ko) 1989-03-27
DK173033B1 (da) 1999-11-29
IE870925L (en) 1987-10-11
US4803081A (en) 1989-02-07
ZA871911B (en) 1987-12-30
UA12336A (uk) 1996-12-25
EG18265A (en) 1992-12-30
EP0249587A1 (fr) 1987-12-16
NO174795B (no) 1994-04-05
FI871585A (fi) 1987-10-12
SG4295G (en) 1995-06-16
CA1304294C (fr) 1992-06-30
ATE76288T1 (de) 1992-06-15
IS3214A7 (is) 1987-10-12
HU204699B (en) 1992-02-28
NZ219633A (en) 1989-11-28
FI91826C (fi) 1994-08-25
GR3005286T3 (fr) 1993-05-24
DD263231A5 (de) 1988-12-28
IE59419B1 (en) 1994-02-23
CS270560B2 (en) 1990-07-12
KR950002147B1 (ko) 1995-03-14
ES2031929T3 (es) 1993-01-01
PH22494A (en) 1988-09-12
IS1553B (is) 1994-08-10
CS258787A2 (en) 1989-11-14
YU47258B (sh) 1995-01-31
PT84663A (en) 1987-05-01
NO871199D0 (no) 1987-03-23
HK26795A (en) 1995-03-10
MY101553A (en) 1991-12-17
DE3779183D1 (de) 1992-06-25
CN1025150C (zh) 1994-06-29
FI871585A0 (fi) 1987-04-10
SU1743332A3 (ru) 1992-06-23
AU7004387A (en) 1987-10-15
NO174795C (fr) 1994-07-13
YU40787A (sh) 1992-09-07
NO871199L (no) 1987-10-12
JPH0778016B2 (ja) 1995-08-23
CY1826A (en) 1995-12-01
AU602677B2 (en) 1990-10-25
JPS62242613A (ja) 1987-10-23
KR870009720A (ko) 1987-11-30
PT84663B (pt) 1989-11-30
CN87102758A (zh) 1987-10-21
DK154987D0 (da) 1987-03-26
HUT43786A (en) 1987-12-28
PL265078A1 (en) 1988-07-21

Similar Documents

Publication Publication Date Title
SE8601624D0 (sv) New pharmaceutical preparations
DE3382637D1 (de) Eine lipidloesliche substanz enthaltende waessrige fluessigkeit.
MC2094A1 (fr) Medicament contenant de l'acide dihydrolipoique en tant que substance active,procede de preparation
ATE16191T1 (de) Stabile salze von s-adenosinylmethionin, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen welche als aktive substanz diese derivate enthalten.
LV10954A (lv) Benzimidazola atvasinajumi to iegusanas panemiens un tos saturosa farmaceitiska kompozicija
DK0598770T3 (da) Pyrazinderivater samt fremstilling og anvendelse deraf
ES2041249T3 (es) Preparaciones liquidas de 1,2-benzoisotiazolin-3-ona, su obtencion y empleo.
ATE67406T1 (de) Nicorandil enthaltende zubereitung zum einspritzen.
ATE65401T1 (de) Stabile, injizierbare loesungen von salzen von vincristin.
FR2397191A1 (fr) Preparation stable de chloramphenicol pour injections
NO843296L (no) Fremgangsmaate for fremstilling av benzosyrederivater med antimikrobiell aktivitet
FR2446831A1 (fr) Derive oxyimino-e-homo-eburnane, procede pour le preparer et son utilisation dans une composition pharmaceutique pour la preparation de derives ester de l'acide apovincaminique
BE877050A (fr) Utilisation d'esters d'acides hydroxycarboxyliques aliphatiques en tant que desodorisants
SE8204792L (sv) N-metyl-d-glukaminsalt av 3,4-dihydro-5-metyl-6-(2-metyl-propyl)-4-oxotieno(2,3-d)pyrimidin-2-karboxylsyra och farmaceutisk komposition innehallande detta salt
SE7902817L (sv) Substituerade /4h/ 1,3-bensodioxin-2-karboxylsyraderivat, framstellning och anvendning derav sasom lekemedel samt farmaceutiska kompositioner innehallande dessa
DE68900693D1 (de) Pharmazeutische praeparate zur transdermalen applikation von heparin.
TH3206A (th) สารแขวนลอยซูครัลเฟท